Ignite Creation Date:
2025-12-25 @ 3:33 AM
Ignite Modification Date:
2026-04-24 @ 9:39 PM
Study NCT ID:
NCT03052205
Status:
COMPLETED
Last Update Posted:
2020-02-11
First Post:
2017-02-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Intratumoral IMO-2125 in Patients With Refractory Solid Tumors
Sponsor:
Idera Pharmaceuticals, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
2125-RST-101
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None